201 related articles for article (PubMed ID: 22864788)
21. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers.
Sun JS; Park KJ; Sheen SS; Yoon JK; Yoon SN; Lee KB; Hwang SC
Lung Cancer; 2009 Nov; 66(2):205-10. PubMed ID: 19203812
[TBL] [Abstract][Full Text] [Related]
22. OCIA domain containing 2 is highly expressed in adenocarcinoma mixed subtype with bronchioloalveolar carcinoma component and is associated with better prognosis.
Ishiyama T; Kano J; Anami Y; Onuki T; Iijima T; Morisita Y; Yokota J; Noguchi M
Cancer Sci; 2007 Jan; 98(1):50-7. PubMed ID: 17054434
[TBL] [Abstract][Full Text] [Related]
23. STAT3 expression in activating EGFR-driven adenocarcinoma of the lung.
Takata S; Takigawa N; Segawa Y; Kubo T; Ohashi K; Kozuki T; Teramoto N; Yamashita M; Toyooka S; Tanimoto M; Kiura K
Lung Cancer; 2012 Jan; 75(1):24-9. PubMed ID: 21684622
[TBL] [Abstract][Full Text] [Related]
24. [Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].
Wang CL; Yue DS; Zhang ZF; Zhan ZL; Sun LN
Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2350-4. PubMed ID: 18036300
[TBL] [Abstract][Full Text] [Related]
25. Distinctive evaluation of nonmucinous and mucinous subtypes of bronchioloalveolar carcinomas in EGFR and K-ras gene-mutation analyses for Japanese lung adenocarcinomas: confirmation of the correlations with histologic subtypes and gene mutations.
Sakuma Y; Matsukuma S; Yoshihara M; Nakamura Y; Noda K; Nakayama H; Kameda Y; Tsuchiya E; Miyagi Y
Am J Clin Pathol; 2007 Jul; 128(1):100-8. PubMed ID: 17580276
[TBL] [Abstract][Full Text] [Related]
26. Genetic evolution of epidermal growth factor receptor in adenocarcinoma with a bronchioloalveolar carcinoma component.
Zhong WZ; Wu YL; Yang XN; Guo AL; Su J; Zhang XC; Luo DL; Wang Z; Chen HJ; Zhou Q; Xu CR; Qiao GB; Liao RQ; Yang JJ; Mok TS
Clin Lung Cancer; 2010 May; 11(3):160-8. PubMed ID: 20439191
[TBL] [Abstract][Full Text] [Related]
27. Bronchioloalveolar carcinoma and lung adenocarcinoma: the clinical importance and research relevance of the 2004 World Health Organization pathologic criteria.
Travis WD; Garg K; Franklin WA; Wistuba II; Sabloff B; Noguchi M; Kakinuma R; Zakowski M; Ginsberg M; Padera R; Jacobson F; Johnson BE; Hirsch F; Brambilla E; Flieder DB; Geisinger KR; Thunnissen F; Kerr K; Yankelevitz D; Franks TJ; Galvin JR; Henderson DW; Nicholson AG; Hasleton PS; Roggli V; Tsao MS; Cappuzzo F; Vazquez M
J Thorac Oncol; 2006 Nov; 1(9 Suppl):S13-9. PubMed ID: 17409995
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
[TBL] [Abstract][Full Text] [Related]
29. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung.
Awaya H; Takeshima Y; Yamasaki M; Inai K
Am J Clin Pathol; 2004 May; 121(5):644-53. PubMed ID: 15151204
[TBL] [Abstract][Full Text] [Related]
30. Differentiating bronchioloalveolar carcinoma from adenocarcinoma.
Schraufnagel D; Peloquin A; Paré JA; Wang NS
Am Rev Respir Dis; 1982 Jan; 125(1):74-9. PubMed ID: 6278997
[TBL] [Abstract][Full Text] [Related]
31. Pathology of human bronchioloalveolar carcinoma and its relationship to the ovine disease.
Mornex JF; Thivolet F; De las Heras M; Leroux C
Curr Top Microbiol Immunol; 2003; 275():225-48. PubMed ID: 12596901
[TBL] [Abstract][Full Text] [Related]
32. A somatic TSHR mutation in a patient with lung adenocarcinoma with bronchioloalveolar carcinoma, coronary artery disease and severe chronic obstructive pulmonary disease.
Kim JW; Lee S; Lui N; Choi H; Mulvihill M; Fang LT; Kang HC; Kwon YW; Jablons D; Kim IJ
Oncol Rep; 2012 Oct; 28(4):1225-30. PubMed ID: 22842620
[TBL] [Abstract][Full Text] [Related]
33. High levels of hepatocyte growth factor/scatter factor in diffuse-type bronchioloalveolar cell carcinoma.
Yamashita J; Ogawa M; Nakano S; Okabe K; Abe M; Iwasaki A; Kuwahara M; Yoshinaga Y; Shirakusa T
Cancer; 1998 Nov; 83(10):2091-8. PubMed ID: 9827713
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the immunophenotypes of signet-ring cell carcinoma, solid adenocarcinoma with mucin production, and mucinous bronchioloalveolar carcinoma of the lung characterized by the presence of cytoplasmic mucin.
Tsuta K; Ishii G; Nitadori J; Murata Y; Kodama T; Nagai K; Ochiai A
J Pathol; 2006 May; 209(1):78-87. PubMed ID: 16463270
[TBL] [Abstract][Full Text] [Related]
35. Bronchioloalveolar carcinoma of the lung 3 centimeters or less in diameter: a prognostic assessment.
Sakurai H; Dobashi Y; Mizutani E; Matsubara H; Suzuki S; Takano K; Shindo S; Matsumoto M
Ann Thorac Surg; 2004 Nov; 78(5):1728-33. PubMed ID: 15511463
[TBL] [Abstract][Full Text] [Related]
36. Distribution of basal/myoepithelial markers in benign and malignant bronchioloalveolar proliferations of the lung.
Saad RS; Liu YL; Silverman JF
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):219-25. PubMed ID: 20065853
[TBL] [Abstract][Full Text] [Related]
37. Frequency of EGFR and KRAS mutations in Japanese patients with lung adenocarcinoma with features of the mucinous subtype of bronchioloalveolar carcinoma.
Hata A; Katakami N; Fujita S; Kaji R; Imai Y; Takahashi Y; Nishimura T; Tomii K; Ishihara K
J Thorac Oncol; 2010 Aug; 5(8):1197-200. PubMed ID: 20661086
[TBL] [Abstract][Full Text] [Related]
38. Mucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar features.
Finberg KE; Sequist LV; Joshi VA; Muzikansky A; Miller JM; Han M; Beheshti J; Chirieac LR; Mark EJ; Iafrate AJ
J Mol Diagn; 2007 Jul; 9(3):320-6. PubMed ID: 17591931
[TBL] [Abstract][Full Text] [Related]
39. Stage I pure bronchioloalveolar carcinoma: recurrences, survival and comparison with adenocarcinoma of the lung.
Rena O; Papalia E; Ruffini E; Casadio C; Filosso PL; Oliaro A; Maggi G
Eur J Cardiothorac Surg; 2003 Mar; 23(3):409-14. PubMed ID: 12614815
[TBL] [Abstract][Full Text] [Related]
40. [Clinicopathologic study of pulmonary adenocarcinoma with features of bronchioloalveolar carcinoma].
Luo DL; Liu YH; Zhuang HG; Liao RQ; Luo XL; Xu FP; Zhang F
Zhonghua Bing Li Xue Za Zhi; 2008 Nov; 37(11):737-42. PubMed ID: 19094707
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]